Codes / ICD10CM / M05.2

M05.2 Rheumatoid vasculitis with rheumatoid arthritis

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Rheumatoid vasculitis with rheumatoid arthritis

Summary

Rheumatoid vasculitis with rheumatoid arthritis is a systemic complication of rheumatoid arthritis (RA) characterized by inflammation of blood vessels (vasculitis). It occurs when the immune system’s dysregulation in RA extends to vascular structures, potentially affecting multiple organ systems. This condition reflects the systemic nature of RA and may present with a range of clinical manifestations depending on the vessels involved.

Causes

The exact cause of rheumatoid vasculitis is not fully understood. It is believed to result from chronic inflammation and immune dysregulation associated with rheumatoid arthritis, leading to vascular damage. Autoantibodies, immune complexes, and inflammatory cytokines may contribute to vessel inflammation, though the precise mechanisms remain under investigation.

Risk Factors

  • Long-standing, severe rheumatoid arthritis
  • High disease activity or titers of rheumatoid factor (RF) or anti-citrullinated protein antibodies (ACPA)
  • Presence of subcutaneous nodules
  • Male gender
  • Older age

Symptoms

  • Skin manifestations (e.g., purpura, ulcers, or nodules)
  • Peripheral neuropathy (e.g., mononeuritis multiplex)
  • Systemic symptoms (e.g., fever, weight loss, fatigue)
  • Organ-specific involvement (e.g., renal, gastrointestinal, or cardiac symptoms)

Diagnosis

Diagnosis involves a combination of clinical evaluation, laboratory tests, and imaging. Blood tests may assess inflammation (e.g., ESR, CRP) and autoantibodies. Biopsy of affected tissue (e.g., skin or nerve) can confirm vasculitis. Imaging (e.g., angiography) may evaluate vascular involvement, and other tests (e.g., nerve conduction studies) assess organ-specific damage.

Treatment Options

  • Immunosuppressive therapies (e.g., corticosteroids, methotrexate, or biologics)
  • Management of underlying rheumatoid arthritis
  • Supportive care for organ-specific complications
  • Lifestyle modifications to reduce vascular risk factors

Prognosis and Follow-Up

Prognosis depends on the severity of vasculitis and organ involvement. Early diagnosis and treatment improve outcomes, but severe cases may have significant morbidity. Regular follow-up with rheumatology and relevant specialists (e.g., dermatology, neurology) is essential to monitor disease activity and adjust therapy.

Complications

  • Organ damage (e.g., renal failure, gastrointestinal ischemia)
  • Neurological deficits (e.g., permanent neuropathy)
  • Increased infection risk due to immunosuppression
  • Cardiovascular complications (e.g., vasculitic heart disease)

Lifestyle & Prevention

  • Adherence to RA treatment to control disease activity
  • Smoking cessation to reduce vascular risk
  • Regular monitoring for early signs of vasculitis
  • Prompt reporting of new symptoms to healthcare providers

When to Seek Professional Help

Seek immediate medical attention for:

  • New or worsening skin lesions (e.g., ulcers, purpura)
  • Unexplained neurological symptoms (e.g., numbness, weakness)
  • Systemic signs (e.g., fever, unexplained weight loss)
  • Signs of organ involvement (e.g., abdominal pain, shortness of breath)

Tips for Medical Coders

Document the presence of rheumatoid arthritis and vasculitis, including affected organ systems or clinical manifestations. Ensure specificity in coding by capturing the relationship between RA and vasculitis, as this code requires both conditions to be present. Include details on disease severity, treatment, and complications to support accurate coding and clinical context.

Book a walkthrough

M05.2 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.